Cardiac: Page

  • An aerial view of four clinicians and Distalmotion's Dexter surgical robot.
    Image attribution tooltip
    Permission granted by Distalmotion
    Image attribution tooltip

    Meet 8 medtech companies redefining surgical robotics

    Executives at companies innovating new robotic surgery platforms shared their progress and challenges with MedTech Dive. Read our series of stories on the next generation of surgical robot developers.

    By • Updated June 22, 2026
  • An illustration of the Medtronic OmniaSecure defibrillation lead in the heart.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

    The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate the natural electrical system.

    By • March 25, 2026
  • Three components of Johnson & Johnson's Ottava robotic surgery system are displayed. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Exterior of a modern Thermo Fisher Scientific building featuring a prominent sign above a glass entrance, with cars parked in front.
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher completes $8.9B buyout of Clario

    Thermo Fisher plans to create a fast-growing business by integrating Clario’s data capture and management system with its existing capabilities.

    By • March 25, 2026
  • A closeup of JenaValve's Trilogy transcatheter valve to treat aortic regurgitation.
    Image attribution tooltip
    Permission granted by JenaValve
    Image attribution tooltip

    JenaValve snags FDA approval in aortic regurgitation

    The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

    By • March 18, 2026
  • Field Medical's FieldForce pulsed field ablation system for ventricular tachycardia is displayed.
    Image attribution tooltip
    Courtesy of Field Medical
    Image attribution tooltip

    PFA startup Field Medical appoints Mark Turco as CEO

    Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s aortic and peripheral vascular business.

    By • March 18, 2026
  • The SS Innovations SSi Mantra robotic system.
    Image attribution tooltip
    Permission granted by SS Innovations
    Image attribution tooltip

    SS Innovations raises $18.6M as surgical robot nears US market

    Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.

    By • March 10, 2026
  • Boston Scientific's Farapulse pulsed field ablation system is shown in an operating room.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific gets Farapulse label expansion in Europe

    With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.

    By • March 3, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott wins FDA approval for updated heart failure monitoring device

    The company redesigned the reader to fit in a carry-on suitcase and be easier to use day to day.

    By • March 2, 2026
  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    FDA posts early alert for safety issue with Impella heart pump devices

    The cassettes have an increased risk of purge leaks that can lead to the loss of hemodynamic support.

    By • Feb. 26, 2026
  • A lab technician runs Guardant Health's Shield blood test for colorectal cancer screening in a lab.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Guardant buys MetaSight for $59M upfront to acquire blood test tech

    MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

    By • Feb. 23, 2026
  • A phone screen says "possible hypertension", and a watch next to the phone displays the same message.
    Image attribution tooltip
    Courtesy of Apple
    Image attribution tooltip

    Apple Watch’s hypertension feature may miss some cases, researchers find

    The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high blood pressure, according to the study’s authors. 

    By • Feb. 19, 2026
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards focuses on earlier TAVR adoption

    The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.

    By • Feb. 11, 2026
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    4 takeaways from the 2026 AF Symposium

    Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.

    By • Feb. 10, 2026
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine

    Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.

    By • Feb. 9, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA breakthrough program starts FY2026 at steady pace

    Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.

    By • Feb. 9, 2026
  • Illustration of a heart with a metal, coiled wire going into it.
    Image attribution tooltip
    Courtesy of Abiomed
    Image attribution tooltip

    J&J corrects Impella heart pumps over issue linked to 22 serious injuries

    The urgent correction notice is the latest in a series of actions related to the safety of Impella devices.

    By • Feb. 4, 2026
  • The CathWorks FFRangio System on a cart.
    Image attribution tooltip
    Permission granted by CathWorks
    Image attribution tooltip

    Medtronic to acquire CathWorks for up to $585M

    The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.

    By • Feb. 3, 2026
  • Edwards Lifesciences' Sapien 3 Ultra heart valve replacement system is shown with the valve expanded by a balloon.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards’ request for broader TAVR Medicare coverage gets pushback

    Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but some physicians and rival Medtronic said more data is needed.

    By • Jan. 28, 2026
  • Three clinicians work with a robotic surgery system as a patient lies on the operating table.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip
    Deep Dive

    5 robotic surgery trends to watch in 2026

    Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.

    By • Jan. 27, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for single-shot pulsed field ablation catheter

    Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave catheter.

    By • Jan. 26, 2026
  • Two clinicians wearing scrubs stand in front of Intuitive Surgical's da Vinci 5 robotic surgery system.
    Image attribution tooltip
    Courtesy of Tampa General Hospital
    Image attribution tooltip

    Intuitive’s cardiac initiative includes valve repair, LAA closure

    With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.

    By • Jan. 26, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • An artificial heart valve is pictured against a white background.
    Image attribution tooltip
    Retrieved from Anteris Technologies Global on January 21, 2026
    Image attribution tooltip

    Medtronic to buy up to $90M stake in heart valve developer Anteris

    Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

    By • Jan. 21, 2026
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott gets Europe’s CE mark for dual ablation catheter

    The device can deliver both radiofrequency energy and pulsed field ablation to treat heart arrhythmias.

    By • Jan. 20, 2026
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to acquire Penumbra for $14.5B

    With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

    By • Jan. 15, 2026